Beacon Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$974K Buy
12,456
+253
+2% +$20.4K 0.09% 181
2026
Q1
$1.06M Sell
12,203
-799
-6% -$76.5K 0.11% 162
2025
Q4
$1.25M Sell
13,002
-1,457
-10% -$142K 0.12% 153
2025
Q3
$1.38M Sell
14,459
-153
-1% -$14.1K 0.14% 154
2025
Q2
$1.27M Buy
14,612
+363
+3% +$30.8K 0.13% 150
2025
Q1
$1.28M Buy
14,249
+1,233
+9% +$110K 0.14% 142
2024
Q4
$1.04M Sell
13,016
-2,712
-17% -$235K 0.11% 153
2024
Q3
$1.42M Sell
15,728
-1,455
-8% -$122K 0.15% 140
2024
Q2
$1.35M Sell
17,183
-543
-3% -$44.5K 0.15% 140
2024
Q1
$1.54M Sell
17,726
-1,531
-8% -$131K 0.18% 127
2023
Q4
$1.59M Buy
19,257
+3,022
+19% +$230K 0.19% 122
2023
Q3
$1.32M Sell
16,235
-740
-4% -$61.9K 0.19% 117
2023
Q2
$1.47M Sell
16,975
-598
-3% -$51.5K 0.2% 112
2023
Q1
$1.41M Buy
17,573
+3,555
+25% +$290K 0.2% 113
2022
Q4
$1.09M Sell
14,018
-282
-2% -$22.9K 0.15% 128
2022
Q3
$1.18M Buy
14,300
+1,767
+14% +$159K 0.18% 118
2022
Q2
$1.13M Sell
12,533
-318
-2% -$32.2K 0.17% 126
2022
Q1
$1.44M Buy
12,851
+176
+1% +$18.6K 0.19% 118
2021
Q4
$1.34M Buy
12,675
+3,266
+35% +$378K 0.17% 114
2021
Q3
$1.19M Sell
9,409
-361
-4% -$46.7K 0.16% 121
2021
Q2
$1.23M Sell
9,770
-1,169
-11% -$147K 0.17% 120
2021
Q1
$1.3M Hold
10,939
0.2% 111
2020
Q4
$1.3M Sell
10,939
-1,744
-14% -$192K 0.2% 113
2020
Q3
$1.32M Sell
12,683
-288
-2% -$28.9K 0.24% 105
2020
Q2
$1.17M Buy
12,971
+10,055
+345% +$964K 0.23% 104
2020
Q1
$268K Sell
2,916
-1,997
-41% -$212K 0.06% 160
2019
Q4
$527K Hold
4,913
0.07% 153
2019
Q3
$527K Sell
4,913
-179
-4% -$18.7K 0.09% 139
2019
Q2
$496K Sell
5,092
-218
-4% -$19.9K 0.08% 143
2019
Q1
$484 Sell
5,310
-99
-2% -$8.86K 0.08% 135
2018
Q4
$483K Buy
5,409
+1
+0% +$93 0.09% 131
2018
Q3
$532K Sell
5,408
-68
-1% -$6.29K 0.09% 132
2018
Q2
$469K Sell
5,476
-225
-4% -$18.8K 0.08% 140
2018
Q1
$457K Buy
5,701
+2,302
+68% +$190K 0.08% 145
2017
Q4
$274K Buy
3,399
+1
+0% +$80 0.05% 175
2017
Q3
$264K Buy
3,398
+2
+0.1% +$166 0.05% 176
2017
Q2
$301K Buy
3,396
+1
+0% +$84 0.06% 170
2017
Q1
$274K Sell
3,395
-498
-13% -$38.9K 0.05% 168
2016
Q4
$277K Buy
3,893
+501
+15% +$39.4K 0.06% 168
2016
Q3
$290K Sell
3,392
-685
-17% -$59.7K 0.06% 162
2016
Q2
$348K Buy
4,077
+501
+14% +$40.5K 0.08% 143
2016
Q1
$269K Sell
3,576
-98
-3% -$7.38K 0.06% 156
2015
Q4
$284K Hold
3,674
0.07% 147
2015
Q3
$244K Buy
3,674
+419
+13% +$30.9K 0.06% 148
2015
Q2
$238K Sell
3,255
-150
-4% -$11.5K 0.05% 159
2015
Q1
$268K Buy
3,405
+349
+11% +$26.5K 0.06% 151
2014
Q4
$223K Sell
3,056
-53,086
-95% -$3.69M 0.05% 176
2014
Q3
$3.51M Sell
56,142
-633
-1% -$40.2K 0.76% 45
2014
Q2
$3.64M Buy
56,775
+2,016
+4% +$122K 0.8% 46
2014
Q1
$3.31M Sell
54,759
-1,174
-2% -$68.4K 0.68% 44
2013
Q4
$3.21M Buy
55,933
+483
+0.9% +$27.4K 0.62% 45
2013
Q3
$2.94M Buy
+55,450
New +$2.98M 0.63% 46

Other funds holding MDT

Beacon Financial Group's MDT Position: Q2 2026 in Review

Beacon Financial Group increased its Medtronic (MDT) stake by 2.1% in Q2 2026, buying an estimated $20.4K and bringing the position to 12,456 shares worth $974K. The position accounts for 0.09% of the portfolio, ranked #181.

Beacon Financial Group first reported a position in MDT in Q3 2013 and has held it in 52 quarters since. The position peaked at $3.64M in Q2 2014. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Beacon Financial Group held 12,456 shares of Medtronic worth $974K as of Q2 2026.
  • Beacon Financial Group bought 253 Medtronic shares in Q2 2026, an estimated $20.4K.
  • Medtronic made up 0.09% of Beacon Financial Group's portfolio in Q2 2026, its #181 holding.
  • Beacon Financial Group first reported a position in Medtronic in Q3 2013 and has held it in 52 quarters since.
  • Beacon Financial Group's Medtronic position peaked at $3.64M in Q2 2014.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Beacon Financial Group's 13F filing for Q2 2026, filed 16 Jul 2026.